(Q71725048)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7551941%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Phase II study with paclitaxel for the treatment of advanced inoperable non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7551941%20AND%20SRC:MED&resulttype=core&format=json

non-small-cell lung carcinoma

20 October 2019

main subject

1 reference

1 reference

U Gatzemeier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7551941%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

M Heckmayr

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7551941%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

R Neuhauss

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7551941%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

I Schlüter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7551941%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

J V Pawel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7551941%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

H Wagner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7551941%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

A Dreps

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7551941%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 June 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7551941%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7551941%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

12 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7551941%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

S101-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7551941%20AND%20SRC:MED&resulttype=core&format=json

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

20 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980008-X

7 January 2021

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980008-X

7 January 2021

Preliminary evaluation of a multicenter, randomized comparative study of TAXOL (paclitaxel) dose and infusion length in platinum-treated ovarian cancer. Canadian-European Taxol Cooperative Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980008-X

7 January 2021

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980008-X

7 January 2021

10.1016/S0169-5002(10)80008-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7551941%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference